Mercy's Dr. Jennifer Joh Addresses Triple Negative Breast Cancer
A breast cancer diagnosis can be complex. There are varying types of the disease.
Breast cancer that is not supported by the hormones estrogen and progesterone nor by the presence of too many HER-2 receptors is called triple negative. It's more rare and does not respond to typical breast cancer medicines.
According to dedicated breast surgeon Dr. Jennifer Joh of The Hoffberger Breast Center at Mercy Medical Center, there is tremendous research happening right now.
"Triple negative breast cancer is a very hot topic because we don't really have great ways of treating the breast cancer, and it does tend to be more aggressive and it does tend to lead to reduced survival rates," Dr. Joh said.
Triple negative accounts for just 10 to 20 percent of breast cancer cases and is more common in young women, African-Americans, Hispanics and those with the BRCA1 gene mutation.
View Dr. Jennifer Joh’s interview regarding triple negative breast cancer.
Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on Facebook, Twitter, or call 1-800-MD-Mercy.
Additional Content That Might Interest You